Financial Services

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

Former top U.S. banking regulator Rodney E. Hood joins Northpointe's board, bringing deep expertise to the mortgage-focused bank's strategic goals.

With 10 million users acquired organically, Presentations.AI is leading a shift from static slides to dynamic, AI-powered 'decision infrastructure'.

Lithuania's grid operator reports higher revenue but lower profit, while adjusted figures show strength. The results underscore a pivotal year of European integration.

Kitchen equipment maker Li Bang International is acquiring a major caterer, a bold move to nearly double its revenue and dive into China's booming food service market.

The acquisition aims to bridge the gap between city hall paperwork and public works, creating a single, integrated system for managing modern municipalities.

With U.S. cancer centers tripling adoption of its targeted drug delivery device, RenovoRx signals a potential shift in treating solid tumors.

Former FHA Commissioner Brian Montgomery's move to NewDay USA signals a strategic play to deepen its service to veterans in a complex housing market.

A new AI platform, Rewarx Studio, promises to end distorted product images, offering e-commerce brands photorealistic visuals that build consumer trust.

Everytable lands a $3M deal to feed Phoenix's seniors, marking its Arizona debut and a new model for public-private social welfare partnerships.

The National Hardware Show is radically transforming to meet modern retail demands, connecting innovators directly with global factories and retailers like Lowe's.

Quanta System is ditching distributors for a direct US operation in North Carolina, aiming to shake up the competitive surgical and urology laser market.

Dycom Industries will detail its role in the digital revolution at key investor conferences, backed by record earnings and a major data center acquisition.

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

For the fifth year, Cintas is a Forbes 'Best Employer.' We look inside the culture, the critiques, and how it gives the company a strategic market advantage.

Artera secures the top spot in the 2026 Best in KLAS awards, a win validating its AI-driven approach to revolutionizing patient communication.

A new emergency epilepsy medication for children is now available, offering a faster, easier-to-use option for caregivers to stop prolonged seizures.

Metacon's major Greek hydrogen project hits a key milestone with a €2.6M payment, signaling strong progress in Southern Europe's energy transition.

Scientific Beta co-founder Marc Zieger's move to QuantumStreet AI signals a major shift as AI fintechs aim to dominate institutional investing.

A new technology bypasses device makers to give networks unprecedented control of location data, promising to power a new economy of 'Physical AI'.